Mawson Infrastructure Group Inc. — Director's Dealing 2018

May 8, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2018-03-26

Reporting Person: Sadan Simcha (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-26	Common Stock, par value $0.001 per share	X	144168	$1.9728	Acquired	682843	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-26	Warrants	$1.9728	X	144168	Disposed	2020-11-16	Common Stock (144168)	Direct

Footnotes

F1: The 144,168 shares of common stock of the Issuer were issued upon the exercise of a portion of warrants held by the reporting person.

F2: Represents (i) 567,974 shares of common stock of the Issuer and (ii) 114,869 shares of common stock of the Issuer issuable upon the exercise of warrants.